Identifying PRDX1 as a dominant antioxidant enzyme in breast cancer cells can have significant implications for understanding the biology and pathophysiology of this disease and future design of prooxidant therapies in mammary malignancies. The gene discussed is PRDX1; the disease is breast cancer.